Drugs / Threonyl Muramyl Dipeptide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001042 | ? → Mar 1996 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Threonyl Muramyl Dipeptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001042 ↗ |
| Known as | threonyl MDP | “threonyl muramyl dipeptide (threonyl MDP)” NCT00001042 ↗ |